High expression of FABP4 contributes to the poor prognosis in Ovarian Carcinoma, nonsmall cell lung cancer, Pancreatic Ductal Adenocarcinomas, and hepatocellular carcinoma [30–33]. This evidence concerns the gene FABP4 and ovarian carcinoma.